Heidi Cuthbert

Decidr AI Industries (ASX:DAI) has reported robust operational momentum for the second quarter of FY26, with December 2025 exit revenue reaching an annualised run-rate of $4 million.

FlexiRoam (ASX:FRX) has secured a strategic commercial agreement with DIV Services, a subsidiary of DIALOG Group Berhad, to provide mission-critical connectivity for Malaysia’s MyKasih cashless welfare platform.

RTX Corporation (NYSE:RTX) disclosed that it has received an unsolicited “mini-tender” offer from Tutanota to purchase up to 500,000 shares of RTX common stock at $130 per share.

MarketAxess Holdings (NASDAQ:MKTX) shares were in focus Wednesday after the fixed-income platform operator reported surging volume across its specialized trading protocols for December and the fourth quarter of 2025.

Alcon (NYSE:ALC), the global leader in eye care, officially terminated its definitive merger agreement with STAAR Surgical Company (NASDAQ:STAA) on Tuesday, January 6, 2026.

The collapse of the deal, originally valued at $1.5 billion and later raised to approximately $1.6 billion, follows a decisive rejection by STAAR’s stockholders at a special meeting earlier that day.

Ben Stokes was forced off injured in the final Ashes Test as England’s difficult tour continued in Sydney.

Telegram posted strong H1 revenue growth in 2025, but losses linked to Toncoin and frozen bonds added financial pressure.

Jupiter introduces JupUSD, a new Solana-native stablecoin backed by BlackRock-linked reserves.

The US confirms it is weighing options to acquire Greenland, prompting concern across Europe and Nato.

Ascentage Pharma (NASDAQ:AAPG) shares were in focus on Tuesday, January 6, 2026, following the announcement that the U.S. FDA has cleared its Investigational New Drug (IND) application for APG-3288.